{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T19:25:38Z","timestamp":1788809138932,"version":"build-2803163510"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,9,29]],"date-time":"2018-09-29T00:00:00Z","timestamp":1538179200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s12020-018-1770-6","type":"journal-article","created":{"date-parts":[[2018,9,29]],"date-time":"2018-09-29T05:58:53Z","timestamp":1538200733000},"page":"332-340","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Prevalence and reproductive manifestations of macroprolactinemia"],"prefix":"10.1007","volume":"63","author":[{"given":"Amanpreet Kaur","family":"Kalsi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashutosh","family":"Halder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. K.","family":"Chaturvedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. B.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,29]]},"reference":[{"key":"1770_CR1","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1258\/0004563053857969","volume":"42","author":"MN Fahie-Wilson","year":"2005","unstructured":"M.N. Fahie-Wilson, R. John, A.R. Ellis, Macroprolactin; high molecular mass forms of circulating prolactin. Ann. Clin. Biochem. 42, 175\u2013192 (2005). https:\/\/doi.org\/10.1258\/0004563053857969","journal-title":"Ann. Clin. Biochem."},{"key":"1770_CR2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1590\/S0004-27302002000100007","volume":"46","author":"JGH Vieira","year":"2002","unstructured":"J.G.H. Vieira, Macroprolactinemia. Arq. Bras. Endocrinol. Metab. 46, 45\u201350 (2002)","journal-title":"Arq. Bras. Endocrinol. Metab."},{"key":"1770_CR3","first-page":"128","volume":"8","author":"TS Morteza","year":"2007","unstructured":"T.S. Morteza, A.E. Hossein, K.D. M, Evaluating the prevalence of macroprolactinemia and hyperprolactinemia and comparing their clinical and radiological signs in infertile women. J. Reprod. Infertil. 8, 128\u2013134 (2007)","journal-title":"J. Reprod. Infertil."},{"key":"1770_CR4","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.ejogrb.2004.06.020","volume":"118","author":"A Gezer","year":"2005","unstructured":"A. Gezer, T. Atas\u00fc, C. Hekim, U.H. Stenman, N. Hekim, Hyperprolactinaemia does not always mean\u2019hyperprolactinaemia\u2019! Eur. J. Obstet. Gynecol. Reprod. Biol. 118, 206\u2013208 (2005). https:\/\/doi.org\/10.1016\/j.ejogrb.2004.06.020","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"1770_CR5","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.fertnstert.2016.07.710","volume":"106","author":"KM Genesio Ceratto","year":"2016","unstructured":"K.M. Genesio Ceratto, M.M. Zitta, P. Avalos, M.H. Gomez, C. Avendano, C. Sanchez Sarmiento, Prevalence of macroprolactin (mprl) in infertile female patients: frequent misdiagnosis and mismanagement of hyperprolactinemia. Fertil. Steril. 106, 373 (2016)","journal-title":"Fertil. Steril."},{"key":"1770_CR6","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1007\/s12020-013-9925-y","volume":"44","author":"K Thirunavakkarasu","year":"2013","unstructured":"K. Thirunavakkarasu, P. Dutta, S. Sridhar, L. Dhaliwal, G.R.V. Prashad, S. Gainder, N. Sachdeva, A. Bhansali, Macroprolactinemia in hyperprolactinemic infertile women. Endocrine 44, 750\u2013755 (2013). https:\/\/doi.org\/10.1007\/s12020-013-9925-y","journal-title":"Endocrine"},{"key":"1770_CR7","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1590\/S0004-27302007000100014","volume":"51","author":"L Vilar","year":"2007","unstructured":"L. Vilar, E. Moura, V. Canadas, A. Gusm\u00e3o, R. Campos, E. Leal, L. Teixeira, V. Santos, B. Gomes, M. Lima, R. Paiva, J.L. Albuquerque, C.S. Egito, C.A. Botelho, M. Azevedo, L.A. Casulari, L.A. Naves, Prevalence of macroprolactinemia among 115 patients with hyperprolactinemia]. Arq. Bras. Endocrinol. Metabol. 51, 86\u201391 (2007)","journal-title":"Arq. Bras. Endocrinol. Metabol."},{"key":"1770_CR8","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1210\/jcem.87.2.8272","volume":"87","author":"S Vallette-Kasic","year":"2002","unstructured":"S. Vallette-Kasic, I. Morange-Ramos, A. Selim, G. Gunz, S. Morange, A. Enjalbert, P.-M. Martin, P. Jaquet, T. Brue, Macroprolactinemia revisited: a study on 106 patients. J. Clin. Endocrinol. Metab. 87, 581\u2013588 (2002). https:\/\/doi.org\/10.1210\/jcem.87.2.8272","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1770_CR9","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1530\/acta.0.1280308","volume":"128","author":"T Bj\u00f8ro","year":"1993","unstructured":"T. Bj\u00f8ro, E. Johansen, H.H. Frey, A. Turter, P.A. Torjesen, Different responses in little and bigbig prolactin to metoclopramide in subjects with hyperprolactinemia due to 150-170 kD (bigbig) prolactin. Acta Endocrinol. 128, 308\u2013312 (1993)","journal-title":"Acta Endocrinol."},{"key":"1770_CR10","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1210\/jcem-53-4-863","volume":"53","author":"PG Whittaker","year":"1981","unstructured":"P.G. Whittaker, T. Wilcox, T. Lind, Maintained fertility in a patient with hyperprolactinemia due to big, big prolactin. J. Clin. Endocrinol. Metab. 53, 863\u2013866 (1981). https:\/\/doi.org\/10.1210\/jcem-53-4-863","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1770_CR11","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/S0015-0282(16)46646-X","volume":"38","author":"AN Andersen","year":"1982","unstructured":"A.N. Andersen, H. Pedersen, H. Djursing, B.N. Andersen, H.G. Friesen, Bioactivity of prolactin in a woman with an excess of large molecular size prolactin, persistent hyperprolactinemia and spontaneous conception. Fertil. Steril. 38, 625\u2013628 (1982)","journal-title":"Fertil. Steril."},{"key":"1770_CR12","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1677\/joe.1.06871","volume":"190","author":"N Hattori","year":"2006","unstructured":"N. Hattori, Y. Nakayama, K. Kitagawa, T. Ishihara, Y. Saiki, C. Inagaki, Anti-prolactin (P. R. L.) autoantibody-binding sites (epitopes) on PRL molecule in macroprolactinemia. J. Endocrinol. 190, 287\u2013293 (2006). https:\/\/doi.org\/10.1677\/joe.1.06871","journal-title":"J. Endocrinol."},{"key":"1770_CR13","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1210\/jc.2005-1831","volume":"91","author":"A Glezer","year":"2006","unstructured":"A. Glezer, C.R.J. Soares, J.G. Vieira, D. Giannella-Neto, M.T.C.P. Ribela, V. Goffin, M.D. Bronstein, Human macroprolactin displays low biological activity via its homologous receptor in a new sensitive bioassay. J. Clin. Endocrinol. Metab. 91, 1048\u20131055 (2006). https:\/\/doi.org\/10.1210\/jc.2005-1831","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1770_CR14","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/j.1365-2265.2006.02548.x","volume":"65","author":"A Lea\u00f1os-Miranda","year":"2006","unstructured":"A. Lea\u00f1os-Miranda, G. C\u00e1rdenas-Mondrag\u00f3n, R. Rivera-Lea\u00f1os, A. Ulloa-Aguirre, V. Goffin, Application of new homologous in vitro bioassays for human lactogens to assess the actual bioactivity of human prolactin isoforms in hyperprolactinaemic patients. Clin. Endocrinol. 65, 146\u2013153 (2006). https:\/\/doi.org\/10.1111\/j.1365-2265.2006.02548.x","journal-title":"Clin. Endocrinol."},{"key":"1770_CR15","doi-asserted-by":"publisher","first-page":"3268","DOI":"10.1210\/jc.2010-0114","volume":"95","author":"IR Wallace","year":"2010","unstructured":"I.R. Wallace, N. Satti, C.H. Courtney, H. Leslie, P.M. Bell, S.J. Hunter, D.R. McCance, B. Sheridan, A.B. Atkinson, Ten-year clinical follow-up of a cohort of 51 patients with macroprolactinemia establishes it as a benign variant. J. Clin. Endocrinol. Metab. 95, 3268\u20133271 (2010). https:\/\/doi.org\/10.1210\/jc.2010-0114","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1770_CR16","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s12020-016-0898-5","volume":"53","author":"R Krysiak","year":"2016","unstructured":"R. Krysiak, A. Drosdzol-Cop, V. Skrzypulec-Plinta, B. Okopien, Sexual function and depressive symptoms in young women with elevated macroprolactin content: a pilot study. Endocrine 53, 291\u2013298 (2016). https:\/\/doi.org\/10.1007\/s12020-016-0898-5","journal-title":"Endocrine"},{"key":"1770_CR17","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1210\/jcem-47-4-780","volume":"47","author":"VS Fang","year":"1978","unstructured":"V.S. Fang, S. Refetoff, Heterogeneous human prolactin from a giant pituitary tumor in a patient with panhypopituitarism. J. Clin. Endocrinol. Metab. 47, 780\u2013787 (1978). https:\/\/doi.org\/10.1210\/jcem-47-4-780","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1770_CR18","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1210\/jcem-48-6-1026","volume":"48","author":"NH Farkouh","year":"1979","unstructured":"N.H. Farkouh, M.G. Packer, A.G. Frantz, Large molecular size prolactin with reduced receptor activity in human serum: high proportion in basal state and reduction after thyrotropin-releasing hormone. J. Clin. Endocrinol. Metab. 48, 1026\u20131032 (1979). https:\/\/doi.org\/10.1210\/jcem-48-6-1026","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1770_CR19","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1046\/j.1365-2265.2002.01586.x","volume":"57","author":"OM Hauache","year":"2002","unstructured":"O.M. Hauache, A.J. Rocha, A.C.M. Maia, R.M.B. Maciel, J.G.H. Vieira, Screening for macroprolactinaemia and pituitary imaging studies. Clin. Endocrinol. 57, 327\u2013331 (2002)","journal-title":"Clin. Endocrinol."},{"key":"1770_CR20","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1515\/cclm-2016-0902","volume":"55","author":"M Overgaard","year":"2017","unstructured":"M. Overgaard, S.M. Pedersen, Serum prolactin revisited: parametric reference intervals and cross platform evaluation of polyethylene glycol precipitation-based methods for discrimination between hyperprolactinemia and macroprolactinemia. Clin. Chem. Lab. Med. 55, 1744\u20131753 (2017). https:\/\/doi.org\/10.1515\/cclm-2016-0902","journal-title":"Clin. Chem. Lab. Med."},{"key":"1770_CR21","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1046\/j.1365-2265.2003.01852.x","volume":"59","author":"MWJ Strachan","year":"2003","unstructured":"M.W.J. Strachan, W.L. Teoh, A.C. Don-Wauchope, J. Seth, M. Stoddart, G.J. Beckett, Clinical and radiological features of patients with macroprolactinaemia. Clin. Endocrinol. 59, 339\u2013346 (2003)","journal-title":"Clin. Endocrinol."},{"issue":"Pt3","key":"1770_CR22","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1177\/000456329703400305","volume":"34","author":"MN Fahie-Wilson","year":"1997","unstructured":"M.N. Fahie-Wilson, S.G. Soule, Macroprolactinaemia: contribution to hyperprolactinaemia in a district general hospital and evaluation of a screening test based on precipitation with polyethylene glycol. Ann. Clin. Biochem. 34(Pt3), 252\u2013258 (1997). https:\/\/doi.org\/10.1177\/000456329703400305","journal-title":"Ann. Clin. Biochem."},{"key":"1770_CR23","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1179\/acb.2005.034","volume":"60","author":"C Theunissen","year":"2005","unstructured":"C. Theunissen, J. De Schepper, J. Schiettecatte, P. Verdood, E.L. Hooghe-Peeters, B. Velkeniers, Macroprolactinemia: clinical significance and characterization of the condition. Acta Clin. Belg. 60, 190\u2013197 (2005). https:\/\/doi.org\/10.1179\/acb.2005.034","journal-title":"Acta Clin. Belg."},{"key":"1770_CR24","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1385\/ENDO:22:3:267","volume":"22","author":"E Toldy","year":"2003","unstructured":"E. Toldy, Z. L\u00f6csei, I. Szabolcs, M.I. G\u00f3th, P. Kneffel, D. Sz\u00f6ke, G.L. Kov\u00e1cs, Macroprolactinemia: the consequences of a laboratory pitfall. Endocrine 22, 267\u2013273 (2003). https:\/\/doi.org\/10.1385\/ENDO:22:3:267","journal-title":"Endocrine"},{"key":"1770_CR25","doi-asserted-by":"publisher","first-page":"3927","DOI":"10.1210\/jc.2004-2234","volume":"90","author":"J Gibney","year":"2005","unstructured":"J. Gibney, T.P. Smith, T.J. McKenna, The impact on clinical practice of routine screening for macroprolactin. J. Clin. Endocrinol. Metab. 90, 3927\u20133932 (2005). https:\/\/doi.org\/10.1210\/jc.2004-2234","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1770_CR26","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1530\/eje.0.1300438","volume":"130","author":"N Hattori","year":"1994","unstructured":"N. Hattori, K. Ikekubo, T. Ishihara, K. Moridera, M. Hino, H. Kurahachi, Correlation of the antibody titers with serum prolactin levels and their clinical course in patients with anti-prolactin autoantibody. Eur. J. Endocrinol. 130, 438\u2013445 (1994)","journal-title":"Eur. J. Endocrinol."},{"key":"1770_CR27","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1210\/jcem.75.5.1430082","volume":"75","author":"N Hattori","year":"1992","unstructured":"N. Hattori, T. Ishihara, K. Ikekubo, K. Moridera, M. Hino, H. Kurahachi, Autoantibody to human prolactin in patients with idiopathic hyperprolactinemia. J. Clin. Endocrinol. Metab. 75, 1226\u20131229 (1992). https:\/\/doi.org\/10.1210\/jcem.75.5.1430082","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1770_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-015-0025-2","volume":"15","author":"M Guclu","year":"2015","unstructured":"M. Guclu, S. Cander, S. Kiyici, E. Vatansever, A.B. Hacihasano\u011flu, G. Kisakol, Serum macroprolactin levels in pregnancy and association with thyroid autoimmunity. BMC Endocr. Disord. 15, 31 (2015). https:\/\/doi.org\/10.1186\/s12902-015-0025-2","journal-title":"BMC Endocr. Disord."},{"key":"1770_CR29","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1210\/jcem.86.2.7183","volume":"86","author":"D Pascoe-Lira","year":"2001","unstructured":"D. Pascoe-Lira, G. Duran-Reyes, I. Contreras-Hern\u00e1ndez, L. Manuel-Apolinar, F. Blanco-Favela, A. Lea\u00f1os-Miranda, Frequency of macroprolactinemia due to autoantibodies against prolactin in pregnant women. J. Clin. Endocrinol. Metab. 86, 924\u2013929 (2001). https:\/\/doi.org\/10.1210\/jcem.86.2.7183","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1770_CR30","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1210\/jcem.81.2.8636272","volume":"81","author":"N Hattori","year":"1996","unstructured":"N. Hattori, The frequency of macroprolactinemia in pregnant women and the heterogeneity of its etiologies. J. Clin. Endocrinol. Metab. 81, 586\u2013590 (1996). https:\/\/doi.org\/10.1210\/jcem.81.2.8636272","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1770_CR31","first-page":"207","volume":"34","author":"S Radavelli-Bagatini","year":"2013","unstructured":"S. Radavelli-Bagatini, F.L. Lhullier, E.S. Mallmann, P.M. Spritzer, Macroprolactinemia in women with hyperprolactinemia: a 10-year follow-up. Neuro. Endocrinol. Lett. 34, 207\u2013211 (2013)","journal-title":"Neuro. Endocrinol. Lett."},{"key":"1770_CR32","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1210\/jcem-61-2-258","volume":"61","author":"RD Jackson","year":"1985","unstructured":"R.D. Jackson, J. Wortsman, W.B. Malarkey, Characterization of a large molecular weight prolactin in women with idiopathic hyperprolactinemia and normal menses. J. Clin. Endocrinol. Metab. 61, 258\u2013264 (1985). https:\/\/doi.org\/10.1210\/jcem-61-2-258","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1770_CR33","doi-asserted-by":"publisher","first-page":"3107","DOI":"10.1210\/jcem.82.9.4250","volume":"82","author":"N Hattori","year":"1997","unstructured":"N. Hattori, C. Inagaki, Anti-prolactin (P. R. L.) autoantibodies cause asymptomatic hyperprolactinemia: bioassay and clearance studies of PRL-immunoglobulin G complex. J. Clin. Endocrinol. Metab. 82, 3107\u20133110 (1997). https:\/\/doi.org\/10.1210\/jcem.82.9.4250","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1770_CR34","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1210\/jcem-69-3-585","volume":"69","author":"IS Fraser","year":"1989","unstructured":"I.S. Fraser, Z.G. Lun, J.P. Zhou, A.C. Herington, G. McCarron, I. Caterson, K. Tan, R. Markham, Detailed assessment of big big prolactin in women with hyperprolactinemia and normal ovarian function. J. Clin. Endocrinol. Metab. 69, 585\u2013592 (1989). https:\/\/doi.org\/10.1210\/jcem-69-3-585","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1770_CR35","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.cca.2009.10.020","volume":"411","author":"CR McCudden","year":"2010","unstructured":"C.R. McCudden, J.L. Sharpless, D.G. Grenache, Comparison of multiple methods for identification of hyperprolactinemia in the presence of macroprolactin. Clin. Chim. Acta 411, 155\u2013160 (2010). https:\/\/doi.org\/10.1016\/j.cca.2009.10.020","journal-title":"Clin. Chim. Acta"},{"key":"1770_CR36","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1515\/cclm-2015-1283","volume":"54","author":"G Lippi","year":"2016","unstructured":"G. Lippi, M. Plebani, Macroprolactin: searching for a needle in a haystack? Clin. Chem. Lab. Med. 54, 519\u2013522 (2016). https:\/\/doi.org\/10.1515\/cclm-2015-1283","journal-title":"Clin. Chem. Lab. Med."},{"key":"1770_CR37","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1093\/clinchem\/44.8.1758","volume":"44","author":"JG Vieira","year":"1998","unstructured":"J.G. Vieira, T.T. Tachibana, L.H. Obara, R.M. Maciel, Extensive experience and validation of polyethylene glycol precipitation as a screening method for macroprolactinemia. Clin. Chem. 44, 1758\u20131759 (1998)","journal-title":"Clin. Chem."},{"key":"1770_CR38","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1111\/j.1365-2265.2005.02243.x","volume":"62","author":"J Gibney","year":"2005","unstructured":"J. Gibney, T.P. Smith, T.J. McKenna, Clinical relevance of macroprolactin. Clin. Endocrinol. 62, 633\u2013643 (2005). https:\/\/doi.org\/10.1111\/j.1365-2265.2005.02243.x","journal-title":"Clin. Endocrinol."},{"key":"1770_CR39","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1373\/49.9.1504","volume":"49","author":"AM Suliman","year":"2003","unstructured":"A.M. Suliman, T.P. Smith, J. Gibney, T.J. McKenna, Frequent misdiagnosis and mismanagement of hyperprolactinemic patients before the introduction of macroprolactin screening: application of a new strict laboratory definition of macroprolactinemia. Clin. Chem. 49, 1504\u20131509 (2003)","journal-title":"Clin. Chem."},{"key":"1770_CR40","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1210\/jcem.86.6.7521","volume":"86","author":"H Leslie","year":"2001","unstructured":"H. Leslie, C.H. Courtney, P.M. Bell, D.R. Hadden, D.R. McCance, P.K. Ellis, B. Sheridan, A.B. Atkinson, Laboratory and clinical experience in 55 patients with macroprolactinemia identified by a simple polyethylene glycol precipitation method. J. Clin. Endocrinol. Metab. 86, 2743\u20132746 (2001). https:\/\/doi.org\/10.1210\/jcem.86.6.7521","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1770_CR41","doi-asserted-by":"publisher","first-page":"634349","DOI":"10.1155\/2013\/634349","volume":"2013","author":"A Elenkova","year":"2013","unstructured":"A. Elenkova, Z. Abadzhieva, N. Genov, V. Vasilev, G. Kirilov, S. Zacharieva, Macroprolactinemia in a patient with invasive macroprolactinoma: a case report and minireview. Case Rep. Endocrinol. 2013, 634349 (2013). https:\/\/doi.org\/10.1155\/2013\/634349","journal-title":"Case Rep. Endocrinol."},{"key":"1770_CR42","doi-asserted-by":"publisher","first-page":"3576024","DOI":"10.1155\/2016\/3576024","volume":"2016","author":"FD Dellal","year":"2016","unstructured":"F.D. Dellal, D. Ozdemir, C. Aydin, G. Kaya, R. Ersoy, B. Cakir, Gigantomastia and macroprolactinemia responding to cabergoline treatment: a case report and minireview of the literature. Case Rep. Endocrinol. 2016, 3576024 (2016). https:\/\/doi.org\/10.1155\/2016\/3576024","journal-title":"Case Rep. Endocrinol."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-018-1770-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-018-1770-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-018-1770-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T06:13:31Z","timestamp":1605075211000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-018-1770-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,29]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["1770"],"URL":"https:\/\/doi.org\/10.1007\/s12020-018-1770-6","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,29]]},"assertion":[{"value":"16 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in the study involving human participants were in accordance with the ethical standards of the institutional ethical committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}